Skip to content
Brand AI

DaVita

Controversies

Controversies tied to this brand in public sources. A listing is not a finding of fault.

Back to profile7 entries

  1. 2024

    FTC investigation of dialysis-market conduct

    The Federal Trade Commission began investigating DaVita and Fresenius Medical Care over allegations that their conduct disadvantaged smaller dialysis companies.

    Source

  2. 2021

    Labor-market collusion prosecution

    DaVita and former CEO Kent Thiry were indicted over alleged agreements with Surgical Care Affiliates to suppress competition for certain senior employees. Both were acquitted in 2022.

    Source

  3. 2021

    Employees file no-poach lawsuit against Surgical Care Affiliates, DaVita and USPI

    Lawsuit filed

    A putative class action was filed against Surgical Care Affiliates LLC, DaVita Inc. and United Surgical Partners International, Inc. Plaintiffs accuse the companies of maintaining a multi-year agreement not to solicit each other’s senior-level employees and claim the conduct violates the Sherman Act; the allegations are claims in the lawsuit, not a court determination.

    Source excerpt

    • On Friday, a putative class action lawsuit was filed against Surgical Care Affiliates LLC (SCA), DaVita Inc., and United Surgical Partners International, Inc. (USPI) in the Northern District of Illinois.
    • The plaintiffs claim that this behavior is in violation of the Sherman Act and ask that the court concur with this accusation and certify this case as a class action.
    Source

  4. 2018

    Wrongful-death jury award

    A jury awarded $383 million to families of three patients in wrongful-death claims involving cardiac arrests after treatment at DaVita centers.

    Source

  5. 2018

    Medicare Advantage payment settlement

    DaVita agreed to a $270 million settlement over allegations that inaccurate information contributed to inflated Medicare Advantage payments.

    Source

  6. 2015

    Drug-waste billing settlement

    The company agreed to pay $450 million to settle allegations involving unnecessary disposal of drugs and billing the federal government for the resulting waste.

    Source

  7. 2014

    Physician-kickback settlement

    DaVita agreed to pay $350 million to resolve claims alleging that it provided illegal kickbacks to physicians.

    Source